Project Grant R01HD121802
- Federal Project Grant Award Summary Massachusetts General Hospital received a $449,636 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective July 23, 2025 through June 30, 2027. The grant funds research into a novel small interfering RNA (siRNA)-based treatment approach designed to enhance Gs alpha-mediated hormone signaling in patients with...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a $462,538 Project Grant to Magee-Womens Research Institute and Foundation under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period of June 1, 2026 through May 31, 2028. The award funds research investigating CHD7-dependent regulation of migration and morphogenesis in the context of CHARGE syndrome, a congenital developmental disorder...
- Federal Project Grant Award Summary The University of California, Davis received a $128,898 project grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded August 1, 2025, with completion scheduled for July 31, 2027. This award funds research investigating the three-dimensional (3D) genome-based transcriptional program governing male germline differentiation during...
- Federal Project Grant Award Summary The Broad Institute, Inc. received a $747,000 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded on July 23, 2025, with completion targeted for June 30, 2028. The grant supports research characterizing the genetic etiology of delayed puberty, specifically idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann Syndrome...
- Federal Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded $429,000 in Project Grant funding to the University of Colorado-Denver for research conducted under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award was obligated on August 6, 2025, with a project completion date of July 31, 2027. This R21 mechanism grant supports research utilizing induced pluripotent stem cell (iPSC)...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded The Leland Stanford Junior University a Project Grant totaling $357,237 under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award, effective May 1, 2026, through April 30, 2031, supports the Advanced Stanford Center for Early Human Development (ASCEHND), a T32 research training program designed to develop the next generation of scientists specializing in...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Columbia University's Health Sciences Division a Project Grant totaling $638,625 under the Child Health and Human Development Extramural Research program (CFDA 93.865) effective August 21, 2025, with a completion date of July 31, 2030. The award supports investigator-initiated research examining in vivo regulation of progenitor genome organization and cellular diversity,...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded $606,518 to Magee-Womens Research Institute and Foundation under the Child Health and Human Development Extramural Research program (CFDA 93.865) on June 5, 2025, with a completion date of May 31, 2030. The award funds research to test the safety and feasibility of transplanting human spermatogonial stem cells (hSSCs) and grafting testicular tissues back into human patients who...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Children's Research Institute a $768,372 Project Grant on September 4, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds the Tracking Adverse Prenatal Brain Stressors on Offspring Development (TABS) study, which will deliver comprehensive longitudinal research services examining the neurobiological impacts of maternal...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development awarded $185,388 to the University of California, Irvine under the Child Health and Human Development Extramural Research program (CFDA 93.865) effective September 27, 2025, with completion targeted for June 30, 2028. This project grant supports fundamental research investigating gene regulatory redundancy mechanisms that confer robustness to mammalian developmental programs. The research will...
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $352,600 Project Grant to the University of California, San Francisco (UCSF) on June 1, 2026, through the Child Health and Human Development Extramural Research program (CFDA 93.865). This research project, extending through March 31, 2031, investigates the interplay between the chromatin organizer SATB1 and the transcription factor PIT1 during postnatal maturation of the pituitary gland. The research aims to advance understanding of how these molecular factors regulate gene expression critical to pituitary hormone production, including growth hormone, prolactin, and thyroid-stimulating hormone. By elucidating the mechanisms underlying normal pituitary development, this work has direct implications for understanding combined pituitary hormone deficiency (CPHD) in humans, a condition caused by mutations in PIT1 that impair proper hormone production. The primary deliverables include scientific research and data advancing knowledge of pituitary gland development and chromatin organization mechanisms. The project employs specialized molecular techniques, including an alternative ChIP-seq protocol (UreaChIP-seq), to map SATB1 binding sites and characterize the two-tiered chromatin organization system governing pituitary-specific gene expression. Research findings will contribute to the broader body of knowledge regarding developmental biology and may inform future therapeutic approaches to treating pituitary hormone deficiencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $352.6k | 5/29/26 |